Advances in Molecular Pathology: Advances, cartea 6-1
Editat de Gregory J. Tsongalisen Limba Engleză Hardback – 20 oct 2023
Toate formatele și edițiile | Preț | Express |
---|---|---|
Hardback (2) | 840.54 lei 5-7 săpt. | +31.53 lei 7-11 zile |
Elsevier – 20 oct 2023 | 1065.14 lei 3-5 săpt. | +31.53 lei 7-11 zile |
Elsevier – 7 noi 2022 | 840.54 lei 5-7 săpt. |
Din seria Advances
- 5% Preț: 699.65 lei
- 5% Preț: 826.22 lei
- 5% Preț: 1066.53 lei
- 5% Preț: 1006.02 lei
- 5% Preț: 1064.66 lei
- 5% Preț: 1006.19 lei
- 5% Preț: 1065.38 lei
- 5% Preț: 840.54 lei
- 5% Preț: 1173.21 lei
- 25% Preț: 913.80 lei
- 25% Preț: 546.93 lei
- 25% Preț: 617.73 lei
- 25% Preț: 904.84 lei
- 21% Preț: 689.18 lei
- 25% Preț: 681.60 lei
- 25% Preț: 797.32 lei
- 21% Preț: 768.64 lei
- 25% Preț: 748.93 lei
- 25% Preț: 747.66 lei
- 25% Preț: 807.54 lei
- 5% Preț: 457.36 lei
- 25% Preț: 903.58 lei
- 25% Preț: 621.94 lei
- 25% Preț: 806.56 lei
- 21% Preț: 785.15 lei
- 29% Preț: 825.84 lei
- 21% Preț: 833.83 lei
- 5% Preț: 831.18 lei
- 25% Preț: 632.61 lei
- 21% Preț: 882.29 lei
- 21% Preț: 776.28 lei
- 5% Preț: 840.63 lei
- 5% Preț: 884.05 lei
- 21% Preț: 577.31 lei
- 22% Preț: 940.33 lei
- 5% Preț: 830.42 lei
- 25% Preț: 819.95 lei
- 21% Preț: 812.56 lei
- 5% Preț: 456.65 lei
- 5% Preț: 882.62 lei
- 25% Preț: 564.49 lei
- 25% Preț: 761.02 lei
- 25% Preț: 795.75 lei
- 5% Preț: 796.60 lei
- 25% Preț: 791.57 lei
- 25% Preț: 865.36 lei
- 5% Preț: 807.33 lei
- 25% Preț: 792.96 lei
- 25% Preț: 805.69 lei
Preț: 1065.14 lei
Preț vechi: 1121.20 lei
-5% Nou
Puncte Express: 1598
Preț estimativ în valută:
203.88€ • 214.19$ • 171.34£
203.88€ • 214.19$ • 171.34£
Carte disponibilă
Livrare economică 18 februarie-04 martie
Livrare express 04-08 februarie pentru 41.52 lei
Preluare comenzi: 021 569.72.76
Specificații
Cuprins
The Landscape of Clinical Whole Genome Sequencing and the Emergence of Rapid Genetic Diagnosis in Critical Care
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians